Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Ruhlmann CH"'
Autor:
Ruhlmann CH, Herrstedt J
Publikováno v:
Expert Review of Anticancer Therapy; Feb2012, Vol. 12 Issue 2, p139-150, 12p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jørn Herrstedt, E. Bruera, Fausto Roila, Paul J. Hesketh, Matti Aapro, Christina H Ruhlmann, P. Feyer, Rebecca Clark-Snow, Joseph A. Roscoe, Declan Walsh, Alex Molassiotis, L. Lee Dupuis, Lawrence H. Einhorn, Ian N. Olver, David Warr, Bernardo Leon Rapoport, Karin Jordan, Richard J. Gralla, M. van der Wetering
Publikováno v:
Roila, F, Molassiotis, A, Herrstedt, J, Aapro, M, Gralla, R J, Bruera, E, Clark-Snow, R A, Dupuis, L L, Einhorn, L H, Feyer, P, Hesketh, P J, Jordan, K, Olver, I, Rapoport, B L, Roscoe, J, Ruhlmann, C H, Walsh, D, Warr, D, van der Wetering, M & participants of the MASCC/ESMO Consensus Conference Copenhagen 2015 2016, ' 2016 MASCC and ESMO guideline update for the prevention of chemotherapy-and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients ', Annals of Oncology, vol. 27, no. suppl 5, pp. v119-v133 . https://doi.org/10.1093/annonc/mdw270
Annals of oncology, 27(suppl 5), v119-v133. Oxford University Press
Annals of oncology, 27(suppl 5), v119-v133. Oxford University Press
Despite the considerable progress achieved in the last 30 years, vomiting and, especially, nausea, continue to be two of the most distressing side-effects of cancer chemotherapy. In the late 1990s, several professional organisations published recomme
Autor:
Duggan C; School of Nursing and Midwifery, University of Galway, Galway, Ireland.; Oncology Department, Portiuncula University Hospital, Galway, Ireland., Carr PJ; School of Nursing and Midwifery, University of Galway, Galway, Ireland., Gavin N; Royal Brisbane and Women's Hospital, NHMRC Centre of Research Excellence in Nursing, Centre for Health Practice Innovation, Menzies Health Institute Queensland, Griffith University, Brisbane, Australia., Walsh S; Discipline of Surgery, Lambe Institute, Galway, Ireland., Simpkin A; School of Mathematics, Statistics and Applied Mathematics, University of Galway, Galway , Ireland., Byrnes J; Centre for Applied Health economics, Griffith University, Queensland, Australia., Ruhlmann CH; Department of Oncology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Hernon O; School of Nursing and Midwifery, University of Galway, Galway, Ireland., Chan RJ; School of Nursing, Queensland University of Technology, Brisbane, Australia.
Publikováno v:
The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2024 Aug 30; Vol. 8. Cochrane AN: CD015667. Date of Electronic Publication: 2024 Aug 30.
Autor:
Gideonse BM; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark., Birkeland M; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark., Vilstrup MH; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark.; Department of Radiology and Nuclear Medicine, Esbjerg Hospital, Esbjerg, Denmark., Grupe P; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark., Naghavi-Behzad M; Department of Clinical Research, University of Southern Denmark, Odense, Denmark. MNB91@rsyd.dk.; Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark. MNB91@rsyd.dk.; Centre for Personalized Response Monitoring in Oncology, Odense University Hospital, Odense, Denmark. MNB91@rsyd.dk., Ruhlmann CH; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Oncology, Odense University Hospital, Odense, Denmark., Gerke O; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark., Hildebrandt MG; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark.; Centre for Personalized Response Monitoring in Oncology, Odense University Hospital, Odense, Denmark.; Centre for Innovative Medical Technology, Odense University Hospital, Odense, Denmark.
Publikováno v:
Japanese journal of radiology [Jpn J Radiol] 2024 Jul; Vol. 42 (7), pp. 753-764. Date of Electronic Publication: 2024 Mar 20.
Autor:
Petersen SK; Department of Oncology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern, Denmark. Electronic address: soeren.kjaer@rsyd.dk., Hansen CR; Department of Clinical Research, University of Southern, Denmark; Laboratory of Radiation Physics, Odense University Hospital, Odense, Denmark., Ellebaek E; National Centre for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Schmidt H; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Haslund CA; Department of Oncology, Aalborg University Hospital, Aalborg, Denmark., Ruhlmann CH; Department of Oncology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern, Denmark., Bastholt L; Department of Oncology, Odense University Hospital, Odense, Denmark.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Jul; Vol. 205, pp. 114099. Date of Electronic Publication: 2024 May 07.
Autor:
Holmstroem RB; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Denmark., Pedersen S; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Denmark., Jurlander R; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Denmark., Madsen K; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Denmark., Donia M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Denmark., Ruhlmann CH; Department of Oncology, Odense University Hospital, Denmark., Schmidt H; Department of Oncology, Aarhus University Hospital, Denmark., Haslund CA; Department of Oncology, Aalborg University Hospital, Denmark., Bastholt L; Department of Oncology, Odense University Hospital, Denmark., Svane IM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Denmark. Electronic address: inge.marie.svane@regionh.dk., Ellebaek E; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Denmark. Electronic address: eva.ellebaek.steensgaard@regionh.dk.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 May; Vol. 202, pp. 114023. Date of Electronic Publication: 2024 Mar 19.
Autor:
Christensen SK; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Winther ML; North Denmark Region, Aalborg, Denmark., Laursen IJ; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Madsen FS; Region of Southern Denmark, Odense, Denmark., Brink C; Laboratory of Radiation Physics, Department of Oncology, Odense University Hospital, Odense, Denmark., Brix TH; Department of Endocrinology, Odense University Hospital, Odense, Denmark., Ellebaek E; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark., Svane IM; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark., Hansen FS; Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark., Haslund C; Department of Oncology, Aalborg University Hospital, Aalborg, Denmark., Laursen OK; Department of Oncology, Aalborg University Hospital, Aalborg, Denmark., Schmidt H; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Larsen ID; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Bastholt L; Department of Oncology, Odense University Hospital, Odense, Denmark., Ruhlmann CH; Department of Clinical Research, University of Southern Denmark, Odense, Denmark. christina.ruhlmann@rsyd.dk.; Department of Oncology, Odense University Hospital, Odense, Denmark. christina.ruhlmann@rsyd.dk.
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Apr 10; Vol. 32 (5), pp. 281. Date of Electronic Publication: 2024 Apr 10.
Autor:
Herrstedt J; Department of Clinical Oncology, Zealand University Hospital Roskilde and Naestved, Roskilde; Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Clark-Snow R; Oncology Supportive Care Consultant, Overland Park, USA., Ruhlmann CH; Department of Oncology, Odense University Hospital, Odense; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Molassiotis A; College of Arts, Humanities and Education, University of Derby, Derby, UK., Olver I; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia., Rapoport BL; The Medical Oncology Centre of Rosebank, Johannesburg; Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa., Aapro M; Genolier Cancer Center, Genolier, Switzerland., Dennis K; Division of Radiation Oncology, The Ottawa Hospital and the University of Ottawa, Ottawa, Canada., Hesketh PJ; Division of Hematology Oncology, Lahey Hospital and Medical Center, Burlington., Navari RM; World Health Organization, Birmingham., Schwartzberg L; William N. Pennington Cancer Institute, University of Nevada, Reno School of Medicine, Reno., Affronti ML; Department of Neurosurgery, The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham; Duke University School of Nursing, Duke University, Durham, USA., Garcia-Del-Barrio MA; Pharmacy Department, Clínica Universidad de Navarra, Madrid; School of Pharmacy and Nutrition, Universidad de Navarra, Pamplona, Spain., Chan A; Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California Irvine, Irvine, USA., Celio L; Independent Medical Oncologist, Milan, Italy., Chow R; Temerty Faculty of Medicine, University of Toronto, Toronto, Canada., Fleury M; Department of Oncology, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland., Gralla RJ; Albert Einstein College of Medicine, Jacobi Medical Center, Bronx, USA., Giusti R; Medical Oncology Unit, Sant' Andrea Hospital of Rome, Rome, Italy., Jahn F; Clinic for Internal Medicine IV, Oncology - Hematology - Hemostaseology, University Hospital Halle (Saale), Halle, Germany., Iihara H; Department of Pharmacy, Gifu University Hospital, Gifu, Japan., Maranzano E; University of Perugia, Perugia, Italy., Radhakrishnan V; Department of Medical Oncology, Cancer Institute (WIA), Adyar, Chennai, India., Saito M; Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan., Sayegh P; Department of Pharmacy, OU Health Stephenson Cancer Center, Oklahoma City, USA., Bosnjak S; Department of Supportive Oncology and Palliative Care, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia., Zhang L; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Lee J; College of Nursing and Mo-Im Kim Nursing Research Institute, Yonsei University, Seoul, Korea., Ostwal V; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India., Smit T; The Medical Oncology Centre of Rosebank, Johannesburg., Zilic A; Department of Supportive Oncology and Palliative Care, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia., Jordan K; Department of Hematology, Oncology and Palliative Medicine, Ernst von Bergmann Hospital, Potsdam; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany., Scotté F; ∗Interdisciplinary Patient Pathway Division, Gustave Roussy, Villejuif, France. Electronic address: florian.scotte@gustaveroussy.fr.
Publikováno v:
ESMO open [ESMO Open] 2024 Feb; Vol. 9 (2), pp. 102195. Date of Electronic Publication: 2024 Jan 11.
Autor:
Herrstedt J; Department of Clinical Oncology, Zealand University Hospital Roskilde and Naestved, Vestermarksvej 9, 2. Sal, 4000, Roskilde, Denmark. jherr@regionsjaelland.dk.; Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. jherr@regionsjaelland.dk., Clark-Snow R; Oncology Supportive Care Consultant, Overland Park, KS, USA., Ruhlmann CH; Department of Oncology, Odense University Hospital, Odense, Denmark.; Department of Clnical Research, University of Southern Denmark, Odense, Denmark., Jordan K; Department of Hematology, Oncology and Palliative Medicine, Ernst Von Bergmann Hospital, Potsdam, Germany.; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany., Scotté F; Interdisciplinary Patient Pathway Division, Gustave Roussy, Villejuif, France.
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2023 Dec 22; Vol. 32 (1), pp. 57. Date of Electronic Publication: 2023 Dec 22.